✦ LIBER ✦

Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals

✍ Scribed by Shimon Slavin; Mehmet Aker; Michael Y Shapira; Soumya Panigrahi; Cividalli Gabriel; Reuven Or

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonmyeloablative stem cell transplantati

✍ Shimon Slavin; Reuven Or; Memet Aker; Michael Y. Shapira; Soumya Panigrahi; Argi 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 85 KB

Non-myeloablative stem cell transplantat

✍ S. Slavin; A. Nagler; M. Shapira; S. Panigrahi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 14 KB

Smarter rather than stronger treatment o

✍ Shimon Slavin 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 89 KB

Increasing mixed chimerism and the risk

✍ Ozyurek, E; Cowan, M J; Koerper, M A; Baxter-Lowe, L-A; Dvorak, C C; Horn, B N 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 186 KB

Non-Myeloablative (NMA) Allogeneic Hemat

✍ Brammer, Jonathan E.; Stentz, Alex; Dibb, James; Frires, Rachel; Meyers, Gabriel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PCN68 Cost-Effectiveness and Quality of

✍ Le Corroller Soriano, A.G.; Siani, C.; Tabrizi, R.; Michallet, M.; Bay, J.O.; Fa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB